Showing results (741-750 of 921) with videos related to
Sort By:
Pageof 93
Plos One|May 9, 2014
Shorter men live longer: association of height with longevity and FOXO3 genotype in American men of Japanese ancestryQimei He, Brian J Morris, John S Grove, et al.Journal of Hypertension|August 9, 2022
Forkhead box O3 longevity genotype may attenuate the impact of hypertension on risk of intracerebral haemorrhageKazuma Nakagawa, Randi Chen, Steven M Greenberg, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 8, 2018
Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell TransplantationNarendranath Epperla, Mehdi Hamadani, Kwang W Ahn, et al.Journal of Natural Products|December 5, 2008
Citreamicins with potent gram-positive activityD Craig Hopp, Dennis J Milanowski, Joshua Rhea, et al.Journal of Hematology & Oncology|September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapyGregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.Archives of Pathology & Laboratory Medicine|June 3, 2006
Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinomaKelly J Butnor, Andrew G Nicholson, D Craig Allred, et al.Physical Review Letters|May 15, 2002
Measurement of the current-density profile and plasma dynamics in the reversed-field pinchD L Brower, W X Ding, S D Terry, et al.Lancet (London, England)|August 9, 2003
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancerJenny C Chang, Eric C Wooten, Anna Tsimelzon, et al.Clinical Breast Cancer|January 13, 2004
Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary resultsAndrea E Van Pelt, Syed Mohsin, Richard M Elledge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotypeDang M Nguyen, Kathy Sam, Anna Tsimelzon, et al.Pageof 93